Acorai

Cardiovascular Repercussions Caused by COVID-19

By Acorai / January 17, 2023

Heart failure patients are at significantly elevated risk of a COVID-19 infection, but also fully healthy individuals have a substantially elevated risk of cardiovascular complications within the first year after even a mild infection. A recent article on the Acorai blog focused on how the Sars-CoV-2 pandemic has reshaped the clinical management of heart failure,…

Read More

How COVID-19 Affected Heart Failure Management

By Acorai / December 15, 2022

The consequence of Covid-19 At the outbreak of the pandemic in early 2020, there was a unanimously manifest worry among cardiologists that heart failure admissions and mortality would rise steeply. This article attempts explaining some of the causes for the significant drop in admissions and what we could learn from it in future heart failure…

Read More

Understanding the impact of the STRONG-HF trial

By Acorai / November 22, 2022

The New Duo in Heart Failure Management? We may witness the marriage of two macro trends in heart failure management – of the recently further manifested advantages of using NT-proBNP and of the routine use of a wireless heart monitor. Will the routine test happily live ever after with a non-invasive intracardiac pressure device? Cardiologists…

Read More

Navigating the New Age of MedTech Sales & Marketing Series: Healthcare Equity

By Acorai / October 9, 2022

Equity in healthcare & access to care In this second edition of our blog series, we will explore the problems of equality and equity in society and healthcare. We define and give an example of the differences between equality and equity and explore the impact of inequality in healthcare. We aim to outline some practical…

Read More

Mitigating Heart Failure Readmission

By Acorai / September 6, 2022

Readmission Mitigation: A Summary Historical studies suggest that high-volume hospitals may have lower readmission rates for heart failure patients and the concentrations of highly specialised practitioners were the formula for readmission mitigation strategies. Recent studies, however, have shown the opposite relation – despite having proven to reduce surgery complications and hospital mortality, their readmission rates…

Read More

Two Proven Strategies to Reduce Readmission

By Acorai / August 7, 2022

Practices to Reduce Readmissions? We previously categorized the causes of readmissions into the following groups; Preconditions, Lifestyle, Economic status, Treatment outcome and heart failure monitoring. Yet, when we look at the factors reducing readmission and how they relate to the causes of readmission, most causes can categorize most of them as either: Patient education measures…

Read More

How to Reduce Heart Failure Readmission

By Acorai / July 24, 2022

Factors reducing readmission Factors that reduce rehospitalisation rates at discharge are most substantial when evaluating Post-discharge self-care and lifestyle factors. In general, self-care education is known to reduce hospital admissions for all condition types, and the effects of these interventions are also in post-discharge HF patient populations.  It is often intuitive that patient education and…

Read More

Navigating the New Age of MedTech Sales & Marketing series: Buying Behaviours

By Acorai / July 17, 2022

Changing market landscape and procurement behaviours In the first part of our blog series, we will explore how consumers’ purchasing behaviours have changed over the last decade, the current state of medical science sales dynamics and what changes that can come into place to evolve the lagging commercial climate within the life science and MedTech…

Read More

Heart Failure and the Factors Increasing Readmission

By Acorai / July 3, 2022

Our Current Understanding of Readmissions It is well established that patients with heart failure are at least twice as likely to be admitted for in-hospital patient stay and treatment than their age-matched population controls without heart failure. Whilst the pattern of admission and readmission for this patient population is understood, there is a gap for…

Read More

The Current State of Heart Failure Readmission

By Acorai / June 5, 2022

Context of Readmissions In hospital care settings, Heart Failure (HF) treatment and management are among the leading causes of in-patient admissions, conferring one of the single largest economically expensive and resource-intensive pathologies faced in modern healthcare. Of this economic burden, patient readmission makes up the most significant proportion of the costs associated with patient management,…

Read More